Deuterated melflufen compounds
US12152087B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 17, 2019 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | Nov 24, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound of formula (I), or a pharmaceutically acceptable salt thereof (Formula I), wherein, each R1-R30 is independently selected from the group consisting of H and deuterium, and at least one of R1-R30 is deuterium with an abundance level greater than the naturally occurring abundance of deuterium. The invention also provides pharmaceutical compositions containing the compounds, and uses of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.